{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T09:28:22Z","timestamp":1790155702192,"version":"4.0.1"},"reference-count":33,"publisher":"Oxford University Press (OUP)","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2010,1]]},"DOI":"10.1093\/eurheartj\/ehp387","type":"journal-article","created":{"date-parts":[[2009,9,23]],"date-time":"2009-09-23T00:19:17Z","timestamp":1253665157000},"page":"67-76","source":"Crossref","is-referenced-by-count":71,"title":["Evidence for a role of sphingosine-1 phosphate in cardiovascular remodelling in Fabry disease"],"prefix":"10.1093","volume":"31","author":[{"given":"Noureddine","family":"Brakch","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olivier","family":"Dormond","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Soumeya","family":"Bekri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dela","family":"Golshayan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Magali","family":"Correvon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lucia","family":"Mazzolai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Beat","family":"Steinmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fr\u00e9d\u00e9ric","family":"Barbey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2009,9,22]]},"reference":[{"key":"key\n\t\t\t\t20170515123930_EHP387C1","first-page":"3733","article-title":"\u03b1-Galactosidase A deficiency: Fabry disease","volume-title":"The Metabolic and Molecular Bases of Inherited Disease","year":"2001"},{"key":"key\n\t\t\t\t20170515123930_EHP387C2","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1111\/j.1365-2362.2004.01309.x","article-title":"Fabry disease defined: baseline clinical manifestations of 366 patients in the Fabry Outcome Survey","volume":"34","year":"2004","journal-title":"Eur J Clin Invest"},{"key":"key\n\t\t\t\t20170515123930_EHP387C3","doi-asserted-by":"crossref","first-page":"1668","DOI":"10.1016\/S0735-1097(02)02380-X","article-title":"Cardiac manifestations of Anderson-Fabry disease in heterozygous females","volume":"40","year":"2002","journal-title":"J Am Coll Cardiol"},{"key":"key\n\t\t\t\t20170515123930_EHP387C4","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1161\/01.ATV.0000209649.60409.38","article-title":"Cardiac and vascular hypertrophy in Fabry disease: evidence for a new mechanism independent of blood pressure and glycosphingolipid deposition","volume":"26","year":"2006","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"key\n\t\t\t\t20170515123930_EHP387C5","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1067\/mhj.2000.105105","article-title":"New insights in cardiac structural changes in patients with Fabry's disease","volume":"139","year":"2000","journal-title":"Am Heart J"},{"key":"key\n\t\t\t\t20170515123930_EHP387C6","doi-asserted-by":"crossref","first-page":"1265","DOI":"10.1016\/j.echo.2008.09.002","article-title":"Right ventricular involvement in Fabry disease","volume":"21","year":"2008","journal-title":"J Am Soc Echocardiogr"},{"key":"key\n\t\t\t\t20170515123930_EHP387C7","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1111\/j.1651-2227.2002.tb03113.x","article-title":"Arterial remodelling in Fabry disease","volume":"91","year":"2002","journal-title":"Acta Paediatr"},{"key":"key\n\t\t\t\t20170515123930_EHP387C8","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1007\/s10545-006-0340-x","article-title":"Structural and functional changes in peripheral vasculature of Fabry patients","volume":"29","year":"2006","journal-title":"J Inherit Metab Dis"},{"key":"key\n\t\t\t\t20170515123930_EHP387C9","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1056\/NEJM199102073240607","article-title":"An atypical variant of Fabry's disease with manifestations confined to the myocardium","volume":"324","year":"1991","journal-title":"N Engl J Med"},{"key":"key\n\t\t\t\t20170515123930_EHP387C10","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1007\/BF01606034","article-title":"Cardiocyte storage and hypertrophy as a sole manifestation of Fabry's disease. Report on a case simulating hypertrophic non-obstructive cardiomyopathy","volume":"417","year":"1990","journal-title":"Virchows Arch A Pathol Anat Histopathol"},{"key":"key\n\t\t\t\t20170515123930_EHP387C11","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1093\/ejechocard\/jen137","article-title":"Investigating the European Society of Cardiology Diastology Guidelines in a practical scenario","volume":"9","year":"2008","journal-title":"Eur J Echocardiogr"},{"key":"key\n\t\t\t\t20170515123930_EHP387C12","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.jchromb.2005.06.040","article-title":"A rapid and validated HPLC method to quantify sphingosine 1-phosphate in human plasma using solid-phase extraction followed by derivatization with fluorescence detection","volume":"824","year":"2005","journal-title":"J Chromatogr B Analyt Technol Biomed Life Sci"},{"key":"key\n\t\t\t\t20170515123930_EHP387C13","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1161\/01.HYP.0000140269.55873.7b","article-title":"Endogenous angiotensin II induces atherosclerotic plaque vulnerability and elicits a Th1 response in ApoE-\/- mice","volume":"44","year":"2004","journal-title":"Hypertension"},{"key":"key\n\t\t\t\t20170515123930_EHP387C14","doi-asserted-by":"crossref","first-page":"2812","DOI":"10.1073\/pnas.0712309105","article-title":"Elevated globotriaosylsphingosine is a hallmark of Fabry disease","volume":"105","year":"2008","journal-title":"Proc Natl Acad Sci USA"},{"key":"key\n\t\t\t\t20170515123930_EHP387C15","doi-asserted-by":"crossref","first-page":"289","DOI":"10.2174\/187152506778520718","article-title":"The role of ceramide trihexoside (globotriaosylceramide) in the diagnosis and follow-up of the efficacy of treatment of Fabry disease: a review of the literature","volume":"4","year":"2006","journal-title":"Cardiovasc Hematol Agents Med Chem"},{"key":"key\n\t\t\t\t20170515123930_EHP387C16","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1038\/nrm2329","article-title":"Principles of bioactive lipid signalling: lessons from sphingolipids","volume":"9","year":"2008","journal-title":"Nat Rev Mol Cell Biol"},{"key":"key\n\t\t\t\t20170515123930_EHP387C17","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1016\/j.bbalip.2008.04.003","article-title":"Sphingosine-1-phosphate signaling and biological activities in the cardiovascular system","volume":"1781","year":"2008","journal-title":"Biochim Biophys Acta"},{"key":"key\n\t\t\t\t20170515123930_EHP387C18","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1093\/cvr\/cvp030","article-title":"Sphingomyelinases: their regulation and roles in cardiovascular pathophysiology","volume":"82","year":"2009","journal-title":"Cardiovasc Res"},{"key":"key\n\t\t\t\t20170515123930_EHP387C19","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1016\/j.bbalip.2008.07.003","article-title":"The vascular S1P gradient-cellular sources and biological significance","volume":"1781","year":"2008","journal-title":"Biochim Biophys Acta"},{"key":"key\n\t\t\t\t20170515123930_EHP387C20","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/j.plipres.2007.03.001","article-title":"Metabolism and biological functions of two phosphorylated sphingolipids, sphingosine 1-phosphate and ceramide 1-phosphate","volume":"46","year":"2007","journal-title":"Prog Lipid Res"},{"key":"key\n\t\t\t\t20170515123930_EHP387C21","doi-asserted-by":"crossref","first-page":"42422","DOI":"10.1074\/jbc.M405432200","article-title":"Sphingosine 1-phosphate stimulates smooth muscle cell differentiation and proliferation by activating separate serum response factor co-factors","volume":"279","year":"2004","journal-title":"J Biol Chem"},{"key":"key\n\t\t\t\t20170515123930_EHP387C22","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1111\/j.1651-2227.2007.00207.x","article-title":"Vascular effects of sphingolipids","volume":"96","year":"2007","journal-title":"Acta Paediatr Suppl"},{"key":"key\n\t\t\t\t20170515123930_EHP387C23","doi-asserted-by":"crossref","first-page":"1589","DOI":"10.1006\/jmcc.2001.1433","article-title":"EDG1 receptor stimulation leads to cardiac hypertrophy in rat neonatal myocytes","volume":"33","year":"2001","journal-title":"J Mol Cell Cardiol"},{"key":"key\n\t\t\t\t20170515123930_EHP387C24","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1172\/JCI200418004","article-title":"HDL induces NO-dependent vasorelaxation via the lysophospholipid receptor S1P3","volume":"113","year":"2004","journal-title":"J Clin Invest"},{"key":"key\n\t\t\t\t20170515123930_EHP387C25","doi-asserted-by":"crossref","first-page":"1104","DOI":"10.1006\/bbrc.1993.1163","article-title":"Molecular cloning of a novel putative G protein-coupled receptor expressed in the cardiovascular system","volume":"190","year":"1993","journal-title":"Biochem Biophys Res Commun"},{"key":"key\n\t\t\t\t20170515123930_EHP387C26","doi-asserted-by":"crossref","first-page":"9308","DOI":"10.1016\/S0021-9258(19)38849-0","article-title":"An abundant transcript induced in differentiating human endothelial cells encodes a polypeptide with structural similarities to G-protein-coupled receptors","volume":"265","year":"1990","journal-title":"J Biol Chem"},{"key":"key\n\t\t\t\t20170515123930_EHP387C27","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1124\/mol.58.2.449","article-title":"Evidence for Edg-3 receptor-mediated activation of I(K.ACh) by sphingosine-1-phosphate in human atrial cardiomyocytes","volume":"58","year":"2000","journal-title":"Mol Pharmacol"},{"key":"key\n\t\t\t\t20170515123930_EHP387C28","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1177\/002215540205000507","article-title":"Cell type-specific localization of human cardiac S1P receptors","volume":"50","year":"2002","journal-title":"J Histochem Cytochem"},{"key":"key\n\t\t\t\t20170515123930_EHP387C29","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1172\/JCI10905","article-title":"Edg-1, the G protein-coupled receptor for sphingosine-1-phosphate, is essential for vascular maturation","volume":"106","year":"2000","journal-title":"J Clin Invest"},{"key":"key\n\t\t\t\t20170515123930_EHP387C30","doi-asserted-by":"crossref","first-page":"3665","DOI":"10.1182\/blood-2003-02-0460","article-title":"G-protein-coupled receptor S1P1 acts within endothelial cells to regulate vascular maturation","volume":"102","year":"2003","journal-title":"Blood"},{"key":"key\n\t\t\t\t20170515123930_EHP387C31","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/j.bbrc.2006.05.119","article-title":"Negative regulation of endothelial morphogenesis and angiogenesis by S1P2 receptor","volume":"346","year":"2006","journal-title":"Biochem Biophys Res Commun"},{"key":"key\n\t\t\t\t20170515123930_EHP387C32","doi-asserted-by":"crossref","first-page":"1403","DOI":"10.1161\/CIRCULATIONAHA.105.607135","article-title":"High-density lipoproteins and their constituent, sphingosine-1-phosphate, directly protect the heart against ischemia\/reperfusion injury in vivo via the S1P3 lysophospholipid receptor","volume":"114","year":"2006","journal-title":"Circulation"},{"key":"key\n\t\t\t\t20170515123930_EHP387C33","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1080\/08035320600618924","article-title":"Increased carotid intima-media thickness in the absence of atherosclerotic plaques in an adult population with Fabry disease","volume":"95","year":"2006","journal-title":"Acta Paediatr"}],"container-title":["European Heart Journal"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/eurheartj\/article-pdf\/31\/1\/67\/17048683\/ehp387.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,10,11]],"date-time":"2021-10-11T02:45:30Z","timestamp":1633920330000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/eurheartj\/article-lookup\/doi\/10.1093\/eurheartj\/ehp387"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,9,22]]},"references-count":33,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2009,9,22]]},"published-print":{"date-parts":[[2010,1]]}},"URL":"https:\/\/doi.org\/10.1093\/eurheartj\/ehp387","relation":{},"ISSN":["0195-668X","1522-9645"],"issn-type":[{"value":"0195-668X","type":"print"},{"value":"1522-9645","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,9,22]]}}}